Danielle Li
Title
Cited by
Cited by
Year
Discretion in hiring
M Hoffman, LB Kahn, D Li
The Quarterly Journal of Economics 133 (2), 765-800, 2018
1932018
Public R&D investments and private-sector patenting: evidence from NIH funding rules
P Azoulay, JS Graff Zivin, D Li, BN Sampat
The Review of Economic Studies 86 (1), 117-152, 2018
1872018
Big names or big ideas: Do peer-review panels select the best science proposals?
D Li, L Agha
Science 348 (6233), 434-438, 2015
1702015
Expertise versus Bias in Evaluation: Evidence from the NIH
D Li
American Economic Journal: Applied Economics 9 (2), 60-92, 2017
158*2017
The applied value of public investments in biomedical research
D Li, P Azoulay, BN Sampat
Science 356 (6333), 78-81, 2017
1062017
Promotions and the peter principle
A Benson, D Li, K Shue
The Quarterly Journal of Economics 134 (4), 2085-2134, 2019
762019
. School Accountability and Principal Mobility: How No Child Left Behind Affects the Allocation of School Leaders∗
D Li
572012
Developing Novel Drugs
JL Krieger, D Li, D Papanikolaou
National Bureau of Economic Research, 2018
362018
Missing novelty in drug development
JL Krieger, D Li, D Papanikolaou
National Bureau of Economic Research, 2018
272018
Cheaper by the dozen: Using sibling discounts at Catholic schools to estimate the price elasticity of private school attendance
S Dynarski, J Gruber, D Li
National Bureau of Economic Research, 2009
242009
Hiring as Exploration
D Li, LR Raymond, P Bergman
National Bureau of Economic Research Working Paper Series, 2020
9*2020
Scientific Grant Funding
P Azoulay, D Li
National Bureau of Economic Research Working Paper Series, 2020
92020
Trust, collaboration, and economic growth
J Kondo, D Li, D Papanikolaou
Management Science 67 (3), 1825-1850, 2021
42021
Insurance Design and Pharmaceutical Innovation
L Agha, S Kim, D Li
National Bureau of Economic Research Working Paper Series, 2020
22020
Essays on the Organization of Science and Education
D Li
Massachusetts Institute of Technology, 2012
22012
Gender bias in NIH peer review: Does it exist and does it matter?
D Li
22011
Internal Deadlines, Drug Approvals, and Safety Problems
L Cohen, UG Gurun, D Li
American Economic Review: Insights 3 (1), 67-82, 2021
12021
Aspect Ventures
P Gompers, D Li, S Kovvali
2017
TaskRabbit
P Gompers, D Li, S Kovvali
2017
TalentCorp Malaysia and the Returning Expert Programme
WR Kerr, D Li, M Wagner, A Brownell
2017
The system can't perform the operation now. Try again later.
Articles 1–20